Create Account
Log In
Dark
chart
exchange
Premium
Terminal
Screener
Stocks
Crypto
Forex
Trends
Depth
Close
Check out our Level2View

AVXL
Anavex Life Sciences
stock NASDAQ

At Close
Dec 12, 2025 3:59:55 PM EST
4.01USD-2.433%(-0.10)4,861,956
3.45Bid   4.03Ask   0.58Spread
Pre-market
Dec 12, 2025 9:27:30 AM EST
3.68USD-10.462%(-0.43)368,444
After-hours
Dec 12, 2025 4:30:30 PM EST
3.91USD-2.494%(-0.10)6,811
OverviewOption ChainMax PainOptionsPrice & VolumeSplitsHistoricalExchange VolumeDark Pool LevelsDark Pool PrintsExchangesShort VolumeShort Interest - DailyShort InterestBorrow Fee (CTB)Failure to Deliver (FTD)ShortsTrendsNewsNews
Jan 10, 2022
08:14AM EST  Anavex Life's Neurodegenerative Disease Candidate Meets Primary Endpoint In Early-Stage Study   Benzinga
07:04AM EST  Anavex Life Sciences Says its ANAVEX3-71 Reached its Primary and Secondary Endpoints of Safety   Benzinga
07:00AM EST  Anavex Life Sciences Reports Positive Results from Phase 1   GlobeNewswire Inc
Jan 6, 2022
07:00AM EST  Anavex Life Sciences Promotes Walter E Kaufmann, M.D. to Chief   GlobeNewswire Inc
Jan 5, 2022
07:00AM EST  Anavex Life Sciences to Present at the H.C. Wainwright Virtual   GlobeNewswire Inc
Jan 4, 2022
12:53PM EST  Anavex Life Sciences Option Alert: Jan 21 $20 Calls Sweep (6) near the Ask: 250 @ $1.05 vs 3490 OI; Earnings 2/10 Before Open [est] Ref=$16.41   Benzinga
Dec 26, 2021
09:53AM EST  The Week Ahead In Biotech (Dec.26-Jan. 1): Xeris FDA Decision, Pending Clinical Readouts In Focus In Final Week Of Year   Benzinga
Dec 14, 2021
07:00AM EST  Anavex Life Sciences to Present at 40th Annual J.P. Morgan   GlobeNewswire Inc
Nov 29, 2021
07:00AM EST  Anavex Life Sciences to Present at the 4th Annual Evercore ISI   GlobeNewswire Inc
Nov 24, 2021
07:32AM EST  The Daily Biotech Pulse: Kura's Blood Cancer Drug Study Gets Partial Clinical Hold, Takeda FDA Nod, Puma Breast Cancer Treatment Gets Patent Extension   Benzinga
07:09AM EST  Anavex Life Sciences FY21 EPS $(0.54)   Benzinga
07:05AM EST  Anavex Life Sciences FY Net Loss $37.9 Mln Or $0.54/Shr Vs Loss Of $26.3 Mln Or $0.45/Shr Last Year   RTTNews
07:00AM EST  Anavex Life Sciences Provides Business Update and Reports Fiscal   GlobeNewswire Inc
03:35AM EST  Earnings Scheduled For November 24, 2021   Benzinga
Nov 23, 2021
10:40AM EST  Earnings Outlook For Anavex Life Sciences   Benzinga
Nov 21, 2021
03:05PM EST  The Week Ahead In Biotech (Nov. 21-Nov. 27): Takeda, Aadi, Fennec FDA Decisions, Earnings In The Spotlight In Holiday-Shortened Week   Benzinga
Nov 17, 2021
07:00AM EST  Anavex Life Sciences to Announce Fiscal 2021 Year End Financial   GlobeNewswire Inc
Nov 10, 2021
07:07AM EST  Anavex Life Sciences Announces Participation At Upcoming Lausanne VIII Workshop Panel - Building Global Momentum For Interventions In Alzheimer's Disease   Benzinga
07:00AM EST  Anavex Life Sciences Announces Participation at Upcoming Lausanne   GlobeNewswire Inc
Oct 19, 2021
07:20AM EDT  CORRECTION: Anavex Patent 11,103,478 was Granted in August   Benzinga
07:15AM EDT  Anavex Life Sciences Granted U.S. Patent #11,103,478 for 'Anavex2-73 for the treatment of alzheimer's disease'   Benzinga
Oct 15, 2021
07:00AM EDT  Anavex Life Sciences to Present at the Dawson James Securities 6th   GlobeNewswire Inc
Oct 13, 2021
01:38PM EDT  Anavex Life Sciences Reports Data Review by the Independent Data Safety Monitoring Board for its Phase 2b/3 Clinical Trial of ANAVEX 2-73 in Patients with Alzheimer's Disease   Benzinga
07:00AM EDT  Anavex Life Sciences Reports Data Review by the Independent Data   GlobeNewswire Inc
Sep 27, 2021
09:30AM EDT  Anavex Life Sciences Announces Participation at 5th Pharma   GlobeNewswire Inc
07:09AM EDT  Anavex to Uplist to Nasdaq   Benzinga
07:00AM EDT  Anavex Life Sciences Announces Uplisting to the NASDAQ Global   GlobeNewswire Inc
Sep 23, 2021
10:06AM EDT  Benzinga's Top Ratings Upgrades, Downgrades For September 23, 2021   Benzinga
07:54AM EDT  BTIG Initiates Coverage On Anavex Life Sciences with Buy Rating, Announces Price Target of $35   Benzinga
Sep 20, 2021
07:00AM EDT  Anavex Life Sciences to Present at the 2021 Cantor Virtual Global   GlobeNewswire Inc
Sep 9, 2021
07:00AM EDT  Anavex Life Sciences to Present at the H.C. Wainwright   GlobeNewswire Inc
Aug 31, 2021
09:34AM EDT  Anavex Life Sciences Granted U.S. Patent Titled 'Anavex2-73 for the treatment of alzheimer's disease'   Benzinga
Aug 26, 2021
07:08AM EDT  Anavex Life Sciences Announces Publication of Foundational Data for ANAVEX 2-73 in Fragile X Syndrome   Benzinga
07:00AM EDT  Published in Scientific Reports, Results Highlight Reversal of Hyperactivity and Restoration of Associative Learning and Reduction of Anxiety, Phenotypes Associated with Fragile X Syndrome   GlobeNewswire Inc
Aug 25, 2021
01:03PM EDT  Anavex Life Sciences Announces Publication Of Foundational Data For ANAVEX 2-73 In FXS (Autism)   Benzinga
Aug 12, 2021
07:32AM EDT  Anavex Life Sciences Q3 EPS $(0.14) Misses $(0.13) Estimate   Benzinga
07:00AM EDT  Anavex Life Sciences Provides Business Update and Reports Fiscal   GlobeNewswire Inc
04:14AM EDT  Earnings Scheduled For August 12, 2021   Benzinga
Aug 5, 2021
07:00AM EDT  Anavex Life Sciences to Announce Fiscal 2021 Third Quarter   GlobeNewswire Inc
Aug 4, 2021
07:00AM EDT  Anavex Life Sciences to Participate in the BTIG Virtual   GlobeNewswire Inc
Jul 29, 2021
07:25AM EDT  Anavex Life Sciences Corp. Filed U.S. Patent Application #20210228532 'Neurodevelopmental Disorder Therapy'   Benzinga
07:02AM EDT  Anavex Life Sciences Reports Data Showing 'Pre-Treatment with ANAVEX2-73 entirely prevented Abeta-induced cognitive decline'; Says Planning Phase 3 Prevention Trial   Benzinga
07:00AM EDT  Pre-Treatment with ANAVEX2-73 entirely prevented Abeta-induced cognitive decline   GlobeNewswire Inc
Jul 9, 2021
07:33AM EDT  Cramer Shares His Thoughts On Anavex Life Sciences, Upstart And More   Benzinga
Jun 29, 2021
08:17AM EDT  The Daily Biotech Pulse: Sanofi Bets Big On mRNA Tech, Decision Day For MediWound, DiaMedica Issues Kidney Disease Data Readout   Benzinga
Jun 28, 2021
03:46PM EDT  Why This Anavex Life Sciences Analyst Is Lifting Their Price Target   Benzinga
12:23PM EDT  Ladenburg Thalmann Raises Price Target On Anavex Life Sciences From $28.75 To $32.75, Maintains Buy Rating   Benzinga
10:53AM EDT  Anavex Life Sciences Shares Up 14%; Cantor Sets $41 Price Target   Benzinga
10:51AM EDT  Anavex Life Sciences Shares Up 14%; Hearing Cantor Sets $41 Price Target   Benzinga
10:27AM EDT  Shares of Anavex Life Sciences Corp. (AVXL) are climbing more than 14% Monday morning after the company announced positive results from the mid-stage study of its drug candidate Anavex 2-73 in patients with Parkinson's disease dementia.   RTTNews
07:04AM EDT  Anavex Life Sciences Announces ANAVEX2-73 Improved both Primary Cognitive and Secondary MDS-UPDRS Efficacy Endpoints with Significant Biomarker Correlation in Placebo-Controlled Phase 2 Clinical Trial for the Treatment of Patients with Par   Benzinga
07:00AM EDT  ANAVEX2-73 treatment resulted in significant increase in the expression of the SIGMAR1 mRNA biomarker that significantly correlated with improvements in the primary and secondary clinical efficacy endpoints CoA (p = 0.029) and MDS-UPDRS Part III (p = 0.024) and MDS-UPDRS Total (p = 0.038)   GlobeNewswire Inc
06:12AM EDT  HC Wainwright & Co. Maintains Buy on Anavex Life Sciences, Raises Price Target to $39   Benzinga
Jun 24, 2021
04:15PM EDT  Anavex Life Sciences Announces Closing of $50 Million Registered   GlobeNewswire Inc
Jun 22, 2021
11:23AM EDT  Anavex Life Sciences shares were trading lower after the company announced a $50 million registered direct offering.   Benzinga
08:12AM EDT  The Daily Biotech Pulse: Sanofi, Translate Bio Start Early Stage Seasonal Flu Vaccine Study, Dr. Reddy's Launches Generic Vascepa, Halozyme Strikes Licensing Deal   Benzinga
07:12AM EDT  Anavex Life Sciences Announces $50 Million Registered Direct Offering; 2,380,953 Priced At $21/Share   Benzinga
07:00AM EDT  Anavex Life Sciences Announces $50 Million Registered Direct Offering   GlobeNewswire Inc
Jun 21, 2021
10:31AM EDT  Anavex Life's Rett Syndrome Candidate Shows Promising Biomarker Correlating Efficacy Data   Benzinga
10:29AM EDT  Anavex Life Sciences Corp. (AVXL) shares are rising more than 18 percent on Monday morning trade. The company announced positive results from the U.S. Phase 2 study of ANAVEX 2-73 (blarcamesine), the company's drug candidate for the treatment of female adults with Rett syndrome.   RTTNews
07:57AM EDT  Anavex Life Sciences Corp. (AVXL) Monday announced positive results from the U.S. Phase 2 study of ANAVEX 2-73 (blarcamesine), the company's drug candidate for the treatment of female adults with Rett syndrome.   RTTNews
07:11AM EDT  Anavex: ANAVEX2-73 Biomarker Correlated With Efficacy Endpoints In US Phase 2 Trial   RTTNews
07:03AM EDT  Anavex Life Sciences Announces ANAVEX2-73 Biomarker Correlated with Efficacy Endpoints in Placebo-Controlled U.S. Phase 2 Clinical Trial for the Treatment of Adult Patients with Rett Syndrome   Benzinga
07:00AM EDT  ANAVEX2-73 treatment resulted in significant increase in the expression of the SIGMAR1 mRNA biomarker that significantly correlated with improvements in the two primary clinical efficacy endpoints RSBQ (p = 0.035) and CGI-I (p = 0.029)   GlobeNewswire Inc
Jun 16, 2021
02:12PM EDT  Alkermes, Anavex Life Sciences ClinicalTrials.gov Study Record Detail For Co.'s 'Effects of Ketamine on ERP/EEG Measures in Healthy Volunteers,' Shows Not Yet Recruiting   Benzinga
02:09PM EDT  Anavex Life Sciences, Alkermes Post Study Titled 'Effects of Ketamine on ERP/EEG Measures in Healthy Volunteers' To ClinicalTrials.Gov Site   Benzinga
05:02AM EDT  44 Biggest Movers From Yesterday   Benzinga
Jun 15, 2021
06:09AM EDT  HC Wainwright & Co. Maintains Buy on Anavex Life Sciences, Raises Price Target to $25   Benzinga
Jun 14, 2021
09:51AM EDT  Anavex Life Sciences' Alzheimer's Candidate Mechanism Of Action Explained In Medical Journal   Benzinga
07:15AM EDT  CORRECTION: Avenue Therapeutics Ticker Is 'ATXI'   Benzinga
07:03AM EDT  Avenue Therapeutics Receives Complete Response Letter From FDA For IV Tramadol; CRL States That 'the delayed and unpredictable onset of analgesia with IV tramadol does not support its benefit as a monotherapy to treat patients in acute pain'   Benzinga
07:01AM EDT  Anavex Life Sciences Highlights Publication In Medical Journal Elucidating the Mechanism of ANAVEX2-73 And ANAVEX3-71 Related To The Treatment Of Alzheimer's Disease   Benzinga
07:00AM EDT  Anavex Life Sciences Reports New Publication in Medical Journal   GlobeNewswire Inc
Jun 8, 2021
07:14AM EDT  Anavex Says Exceeded Enrollment Target For ANAVEX 2-73 Phase 2b/3 Study In Alzheimer's Disease   RTTNews
07:08AM EDT  Anavex Life Sciences Announces Exceeding Of Enrollment Target For Precision Medicine ANAVEX2-73 Phase 2b/3 Clinical Trial in Patients With Alzheimer's Disease   Benzinga
07:00AM EDT  Anavex Life Sciences Announces Exceeding of Enrollment Target for   GlobeNewswire Inc
Jun 3, 2021
07:00AM EDT  Anavex Life Sciences Announces Notice of Allowance for U.S. Patent   GlobeNewswire Inc
May 26, 2021
07:07AM EDT  Anavex Life Sciences Appoints Jiong Ma To Board   RTTNews
07:00AM EDT  Strengthening Board of Directors with Expertise in Innovative Product Launches   GlobeNewswire Inc
May 13, 2021
08:10AM EDT  The Daily Biotech Pulse: Merck Reports Positive Keytruda Data In Breast Cancer, Curis, Evoke Slump On Earnings, Qiagen's Rapid COVID-19 Antibody Test OK'ed For Emergency Use   Benzinga
07:14AM EDT  Anavex Life Sciences Q2 EPS $(0.12) Beats $(0.14) Estimate   Benzinga
07:00AM EDT  Anavex Life Sciences Reports Fiscal 2021 Second Quarter Financial   GlobeNewswire Inc
04:15AM EDT  Earnings Scheduled For May 13, 2021   Benzinga
May 7, 2021
07:03AM EDT  Anavex Life Sciences Announces Participation At Precision In Clinical Trials Virtual Summit   Benzinga
07:00AM EDT  Anavex Life Sciences Announces Participation at Precision in   GlobeNewswire Inc
May 6, 2021
07:00AM EDT  Anavex Life Sciences to Announce Fiscal 2021 Second Quarter   GlobeNewswire Inc
May 5, 2021
07:00AM EDT  Anavex Life Sciences Appoints Former FDA Officer as Senior Vice   GlobeNewswire Inc
Apr 26, 2021
07:00AM EDT  Anavex Life Sciences to Present at the B. Riley   GlobeNewswire Inc
Apr 12, 2021
07:08AM EDT  Anavex Life Sciences Independent Data Safety Monitoring Board Recommends the Company Continues its Phase 2/3 Trials of ANAVEX Without Modification   Benzinga
07:00AM EDT  Anavex Life Sciences Reports the Results of Review by the   GlobeNewswire Inc
Apr 8, 2021
07:00AM EDT  Anavex Life Sciences to Present at the 20th Annual Needham Virtual   GlobeNewswire Inc
Apr 7, 2021
07:00AM EDT  Anavex Life Sciences Announces Participation at Upcoming World EPA   GlobeNewswire Inc
Mar 31, 2021
07:06AM EDT  Anavex Life Sciences Reports Data Review By The Independent Data Safety Monitoring Board for its Phase 2b/3 Clinical Trial of ANAVEX 2-73 in Patients with Alzheimer's Disease   Benzinga
07:00AM EDT  Anavex Life Sciences Reports Data Review by the Independent Data   GlobeNewswire Inc
Mar 16, 2021
07:00AM EDT  Anavex Life Sciences Reports ANAVEX2-73 (blarcamesine)   GlobeNewswire Inc
Mar 4, 2021
07:00AM EST  Anavex Life Sciences to Present at the H.C. Wainwright Global Life   GlobeNewswire Inc
Mar 2, 2021
05:20AM EST  ANAVEX LIFE SCIENCES Awarded U.S. Patent 10,933,062 'Analgesic therapeutic and method, 1-(3-4(((1 R,3S,5S)-adamantan-1-yl)(phenyl)methyl)propyl)-4-methylpiperazine and salts thereof'   Benzinga
Feb 23, 2021
04:27PM EST  Cantor Fitzgerald Reiterates Overweight on Anavex Life Sciences, Raises Price Target to $25   Benzinga
Feb 22, 2021
07:00AM EST  Anavex Life Sciences Announces Participation at Upcoming Worldwide   GlobeNewswire Inc
Feb 19, 2021
07:17AM EST  Anavex Life Sciences To Participate In Precision In Clinical Trials Virtual Summit Feb. 24 At 3:35 p.m. EST   Benzinga
07:00AM EST  Anavex Life Sciences Announces Participation at Precision in   GlobeNewswire Inc
Feb 18, 2021
07:00AM EST  Anavex Life Sciences to Present at the 10th Annual SVB Leerink   GlobeNewswire Inc
Feb 11, 2021
07:00AM EST  Anavex Life Sciences Reports Fiscal 2021 First Quarter Financial   GlobeNewswire Inc
03:51AM EST  Earnings Scheduled For February 11, 2021   Benzinga
Feb 8, 2021
07:00AM EST  Anavex Life Sciences to Announce Fiscal 2021 First Quarter   GlobeNewswire Inc
Feb 5, 2021
07:44AM EST  The Daily Biotech Pulse: J&J Files For COVID-19 Vaccine Approval, Zimmer Biomet's Spin-Off, IPO Deluge Hits Street   Benzinga
Feb 4, 2021
10:34AM EST  Anavex Life Sciences Corp. (AVXL) shares are rising more than 165 percent on Thursday morning trade, continuing a rally. There has been no specific corporate announcement from the company on Thursday.   RTTNews
10:13AM EST  Mid-Morning Market Update: Markets Open Higher; Bristol-Myers Squibb Profit Beats Estimates   Benzinga
07:22AM EST  The Daily Biotech Pulse: Novartis COVID-19 Drug Readout, Merck And Roche Earnings, 3 IPOs   Benzinga
Feb 3, 2021
10:34AM EST  Anavex Life Sciences Shares Halted On Circuit Breaker; Up 23%   Benzinga
Jan 11, 2021
07:19AM EST  Anavex Life Sciences Receives Research Grant of $995K From Michael J. Fox Foundation for Clinical Study of ANAVEX2-73 in People with Parkinson's Disease   Benzinga
07:00AM EST  Anavex Life Sciences Receives Michael J. Fox Foundation Grant for   GlobeNewswire Inc
Jan 6, 2021
07:00AM EST  Anavex Life Sciences to Present at the H.C. Wainwright Virtual   GlobeNewswire Inc
Dec 28, 2020
07:03AM EST  Anavex Life Sciences FY20 EPS $(0.45) vs $(0.54) In FY19   Benzinga
07:00AM EST  Anavex Life Sciences Reports Fiscal 2020 Year End Financial   GlobeNewswire Inc
04:17AM EST  Earnings Scheduled For December 28, 2020   Benzinga
Dec 22, 2020
07:00AM EST  Anavex Life Sciences to Announce Fiscal 2020 Year End Financial   GlobeNewswire Inc
Dec 21, 2020
07:16AM EST  Anavex Life Sciences Announces Webinar on Rett Syndrome and ANAVEX2-73 (Blarcamesine) Phase 2 Data hosted by Ladenburg Thalmann & Co.   Benzinga
07:00AM EST  Anavex Life Sciences Announces Webinar on Rett Syndrome and   GlobeNewswire Inc
Dec 16, 2020
06:13AM EST  HC Wainwright & Co. Maintains Buy on Anavex Life Sciences, Raises Price Target to $17   Benzinga
Dec 15, 2020
10:39AM EST  Shares of Anavex Life Sciences Corp. (AVXL) are climbing more than 18% Tuesday morning after the company reported positive top line results from a phase II study study of its drug candidate ANAVEX 2-73 (blarcamesine) in adult female patients with Rett syndrome.   RTTNews
07:07AM EST  Anavex Life Sciences Announces ANAVEX2-73 Meets Primary and Secondary Endpoints in Placebo-Controlled U.S. Phase 2 Clinical Trial for the Treatment of Adult Patients with Rett Syndrome   Benzinga
07:00AM EST  Primary safety, pharmacokinetics and secondary efficacy endpoints met, with consistent improvements in RSBQ Total scores and CGI-I   GlobeNewswire Inc
Nov 30, 2020
07:01AM EST  Anavex Life Sciences Announces Notice of Allowance for U.S. Patent Application with Expanding Claims Covering ANAVEX2-73 for the Treatment of Rett Syndrome and other Neurodevelopmental Disorders   Benzinga
07:00AM EST  Anavex Life Sciences Announces Notice of Allowance for U.S. Patent   GlobeNewswire Inc
Nov 25, 2020
07:00AM EST  Anavex Life Sciences to Present at the Evercore ISI 3rd Annual   GlobeNewswire Inc
Nov 6, 2020
10:58AM EST  UPDATE: Anavax Said 'ANAVEX2-73 (blarcamesine) prevented the on-going cognitive decline in treated patients compared to placebo'   Benzinga
10:46AM EST  UPDATE: Anavex Says 'Statistically significant improvements in CDR system Cognitive Domain of Attention assessed by Choice Reaction Time (p = 0.039) and Digital Vigilance (p = 0.008)'   Benzinga
10:46AM EST  Anavex Life Sciences Reports Proof-Of-Concept Controlled Phase 2 Trial Data Evaluating ANAVEX 2-73 In Parkinson's Disease Dementia Presented At Clinical Trials On Alzheimer's Disease Nov. 4-7   Benzinga
10:45AM EST  Statistically significant improvements in CDR system Cognitive Domain of Attention assessed byChoice Reaction Time (p = 0.039) and Digital Vigilance (p = 0.008)   GlobeNewswire Inc
07:47AM EST  The Daily Biotech Pulse: Novartis Drug Flunks COVID-19 Study, Molecular Templates' Blood Cancer Study Placed On Partial Hold   Benzinga
Nov 5, 2020
07:54AM EST  The Daily Biotech Pulse: Bluebird Bio Plunges On Regulatory Filing Delay, Synlogic Soars On Study Initiation, European Label Expansion For Vertex, Merck Goes Shopping   Benzinga
Nov 4, 2020
03:11PM EST  Anavex Life Sciences Option Alert: Nov 20 $7.5 Calls at the Ask: 961 @ $0.451 vs 6396 OI; Earnings 12/14 After Close [est] Ref=$6.42   Benzinga
Oct 21, 2020
06:09AM EDT  HC Wainwright & Co. Maintains Buy on Anavex Life Sciences, Raises Price Target to $14   Benzinga
Oct 15, 2020
07:38AM EDT  Anavex Life Sciences Announces Results From Proof Of Concept Controlled Phase 2 Clinical Trial Of ANAVEX 2-73 In Parkinson's Dementia; Saw 'Clinically meaningful, dose-dependent, and statistically significant improvements in the Cognitive Drug Research (CDR) computerized assessment system analysis'   Benzinga
07:12AM EDT  Anavex Life Sciences Announces Positive Results From Proof Of Concept Controlled Phase 2 Clinical Trial Of ANAVEX2-73   RTTNews
07:04AM EDT  Anavex Life Sciences Announces Results From Proof Of Concept Controlled Phase 2 Clinical Trial Of ANAVEX 2-73 In Parkinson's Dementia; Saw 'Clinically meaningful, dose-dependent, and statistically significant improvements in the Cognitive Drug Research'   Benzinga
07:01AM EDT  Clinically meaningful, dose-dependent, and statistically significant improvements in theCognitive Drug Research(CDR) computerized assessmentsystem analysis   GlobeNewswire Inc
06:58AM EDT  Anavex Life Sciences Shares Are Halted Pending News   Benzinga
Sep 28, 2020
09:31AM EDT  Benzinga's Top Upgrades, Downgrades For September 28, 2020   Benzinga
08:56AM EDT  Ladenburg Thalmann Initiates Coverage On Anavex Life Sciences with Buy Rating, Announces Price Target of $12   Benzinga
Sep 10, 2020
07:09AM EDT  Anavex Life Sciences Announces Completion Of ANAVEX 2-73 US Phase 2 Rett Syndrome Clinical Trial   Benzinga
Sep 8, 2020
07:00AM EDT  Anavex Life Sciences to Present at Upcoming Global Healthcare   GlobeNewswire Inc
Aug 19, 2020
07:00AM EDT  Anavex Life Sciences Announces Commitment for Financial Investment   GlobeNewswire Inc
Aug 6, 2020
09:10AM EDT  Anavex Life Sciences Earlier Reported Q3 EPS $(0.11) Beats $(0.14) Estimate   Benzinga
07:57AM EDT  The Daily Biotech Pulse: FDA Nod For GlaxoSmithKline, Bristol-Myers Squibb Earnings, Acutus Medical IPO   Benzinga
07:01AM EDT  Anavex Life Sciences Reports Fiscal 2020 Third Quarter Financial   GlobeNewswire Inc
Aug 5, 2020
04:33PM EDT  Anavex Life Sciences Receives TGA Special Access Scheme Approval for ANAVEX2-73 for Alzheimer's Disease Patients   Benzinga
04:05PM EDT  Anavex Life Sciences Receives TGA Special Access Scheme Approval   GlobeNewswire Inc
Aug 4, 2020
07:00AM EDT  Anavex Life Sciences to Announce Fiscal 2020 Third Quarter   GlobeNewswire Inc


Share
About
Pricing
Policies
Markets
API
Info
tz UTC-5
Connect with us
ChartExchange Email
ChartExchange on Discord
ChartExchange on X
ChartExchange on Reddit
ChartExchange on GitHub
ChartExchange on YouTube
© 2020 - 2025 ChartExchange LLC